Setting the scene: The Centrality of Partnerships for Launch readiness  5 min

Chair : Troels Sørensen - Global Head Clinical Practice, Boehringer Ingelheim

Talk 1 : Target Population Outputs (TPOs) – is the market leady for launch? 7 min

Troels Sørensen – Head of Global Clinical Practice, Boehringer Ingelheim

Talk 2 : Evidence is the product – is the product launch ready ? 7 min

Laura Wallace – Head of Global Integrated Evidence - Boehringer Ingelheim

Talk 3: Engagement and Strategic PPPs at government level: market shaping for launch and uptake of innovations 7 min

Lena Lymperopoulou - Global Policy Executive, ex Novartis / GSK. Founder of the World Economic Forum Strategic PPPs initiative

Talk 4: Partnerships at health body and regional level: Access and launch readiness 7 min

Danny Moore - Strategic Account Director – Novartis

Talk 5: Partnerships at departmental level: Transforming Field medical to impact accountable launch leaders 7 min

Helen Kane – Global Medical Affairs and Field Medical Affairs Executive - ex-Novarts/Roche/Celgene. Founder of One MSL.

Panel discussion and questions 20 min

·       Focus on the capabilities required by each respective function